TG Therapeutics, Inc. (LON: 0VGI)

TG Therapeutics Revenue

TG Therapeutics had revenue of $83.88M USD in the quarter ending September 30, 2024, a decrease of -49.41%. This brings the company's revenue in the last twelve months to $264.79M, up 39.53% year-over-year. In the year 2023, TG Therapeutics had annual revenue of $233.66M with 8,290.02% growth.

• Revenue (ttm): $264.79M
• Revenue Growth: +39.53%
• P/S Ratio: n/a
• Revenue / Employee: $1.00M
• Employees: 264
• Market Cap: 3.40B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-